News
Philippines’ MPH links top hospitals via OneCare network
Philippines’ MPH links top hospitals via OneCare network
It covers robotic surgery, cancer treatment, and transplant care.
Australian study flags immune resistance in phage therapy treatment
The results from the first VICPhage case highlighted implications for future clinical design.
Taiwan's NTUH opens APAC hub to advance histotripsy cancer treatment
It will establish standardised training programmes.
Hospital networks to drive 6.8% annual growth in digital medical partnerships
Asia Pacific is expanding through public health digitisation, amongst others.
Duke-NUS to build wastewater disease early warning system with $2.3m grant
It is a cost-effective approach to monitoring disease at the community level.
DEE market to surge almost 12% annually on gene therapy advances
Patient pool rises to 326,000 by 2036 across 7MM as diagnosis rates increase.
New Zealand oncology unit cuts travel time for northland patients
It is expected to treat around 370 patients each year initially.
Alcohol-linked liver disease market to see 31% annual growth in next decade
In 2025, the market size was at $145m.
AI in healthcare market targets massive growth as data volumes surge
Asia Pacific is expected to witness the fastest growth.
Chronic conditions fuel demand as pneumonia market expands
It is primarily driven by the ageing population.
Parkway MediCentre taps AeviceMD for home asthma monitoring
The bottle cap-sized device tracks a child’s lung sounds continuously at night.
UTI testing market to reach $78.9b by 2036 on antibiotic resistance, diagnostic demand
India and China are emerging as significant centres due ti high investment.
Japan pressed to act as childhood myopia progresses faster
Experts warn slow adoption could double severe retinal disease by 2050.
Taipei fertility centre deploys AI embryo scoring to tackle implantation failures
One in six people globally is affected by infertility.
Capsule endoscopy market to reach $2.15b by 2033 on GI disease surge
Capsule endoscopy does not support treatment.
Apheresis market to hit $4.4b by 2031 on autoimmune, surgical demand
Asia Pacific is estimated to record the highest CAGR.
Regional travel burdens push KPJ Perdana to expand locally
It is expected to improve access to specialist services within Kelantan.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention